Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G R Evans

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Handbook of Clinical Neurology|November 14, 2015
Neurofibromatosis type 2D G R Evans
Journal of Medical Genetics|November 3, 2009
An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2)D G R Evans, A Wallace
Journal of Medical Genetics|December 10, 2002
Risk assessment and management of high risk familial breast cancerD G R Evans, F Lalloo
The British Journal of Surgery|July 1, 2004
Molecular stool screening for colorectal cancerT Mak, F Lalloo, D G R Evans, et al.
Journal of Medical Genetics|July 5, 2005
Update on the Manchester Scoring System for BRCA1 and BRCA2 testingD G R Evans, F Lalloo, A Wallace, et al.
Journal of Medical Genetics|August 3, 2005
Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanismsD G R Evans, E R Maher, M E Baser
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 11, 2007
The impact of new screening protocol on individuals at increased risk of colorectal cancerT Mak, K Senevrayar, F Lalloo, et al.
British Journal of Cancer|March 5, 2002
A follow-up study of breast and other cancers in families of an unselected series of breast cancer patientsK E Bennett, A Howell, D G R Evans, et al.
Familial Cancer|December 13, 2005
Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutationM E Baser, H Rai, A J Wallace, et al.
Clinical Genetics|February 14, 2009
Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relativesD G R Evans, A Binchy, A Shenton, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Handbook of Clinical Neurology|November 14, 2015
Neurofibromatosis type 2D G R Evans
Journal of Medical Genetics|November 3, 2009
An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2)D G R Evans, A Wallace
Journal of Medical Genetics|December 10, 2002
Risk assessment and management of high risk familial breast cancerD G R Evans, F Lalloo
The British Journal of Surgery|July 1, 2004
Molecular stool screening for colorectal cancerT Mak, F Lalloo, D G R Evans, et al.
Journal of Medical Genetics|July 5, 2005
Update on the Manchester Scoring System for BRCA1 and BRCA2 testingD G R Evans, F Lalloo, A Wallace, et al.
Journal of Medical Genetics|August 3, 2005
Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanismsD G R Evans, E R Maher, M E Baser
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 11, 2007
The impact of new screening protocol on individuals at increased risk of colorectal cancerT Mak, K Senevrayar, F Lalloo, et al.
British Journal of Cancer|March 5, 2002
A follow-up study of breast and other cancers in families of an unselected series of breast cancer patientsK E Bennett, A Howell, D G R Evans, et al.
Familial Cancer|December 13, 2005
Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutationM E Baser, H Rai, A J Wallace, et al.
Clinical Genetics|February 14, 2009
Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relativesD G R Evans, A Binchy, A Shenton, et al.
Pageof 7